In the complex world of pharmaceutical manufacturing, the production cost of Etravirine is a critical consideration for companies engaged in antiviral therapies, particularly in the treatment of HIV. Etravirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is used widely due to its effectiveness in patients who have developed resistance to other HIV medications. Understanding its etravirine …